Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Advances in CNS Tumor Classification through Nanopore Sequencing

4.7

Accredited (Credits: 0.5)
Free
55min
Audio: English

Synopsis

This course examines recent advances in the classification of central nervous system (CNS) tumors through the use of nanopore sequencing technologies. It reviews current classification approaches and highlights how the integration of real-time analysis, adaptive sampling, and advanced algorithms can potentially transform diagnostic and therapeutic decision-making. Aimed at healthcare professionals, the course offers a practical overview of key innovations in oncology, with the potential to shorten diagnostic timelines from weeks to just hours.

Objectives

  • Describe the methods of CNS tumor classification and their importance in diagnosis.
  • Evaluate how nanopore sequencing, combined with the integration of real-time analytics, can enhance accuracy and speed in tumor identification.
  • Analyze the clinical implications of genetic and epigenetic findings in CNS tumor treatment, as well as the role of bioinformatics tools in optimizing the molecular profiling of tumors.

Accreditation

This course is accredited with 0.5 ECMEC credits valid in 26 countries. To claim your credits take the evaluation (satisfaction survey and evaluation questionnaire). You have 3 attempts for the evaluation. You need to pass the evaluation with a sufficient score to validate the course. Your diploma is issued instantaneously and sent to your email.

See more information on the accreditation at: Accreditation

Duration

55min

Target audience

Oncology, Pathology, Neurosurgery, Radiology

Authors

Prof. Matt Loose

Prof. Matt Loose is a Professor of Development and Computational Biology at the University of Nottingham, with extensive experience in using sequencing technologies for oncology research and developing innovative tools for tumor classification.

Testimonials

Read more reviews onTrustpilot

FAQs